Biotricity, Inc. (OTCMKTS:BTCY) Short Interest Update

Biotricity, Inc. (OTCMKTS:BTCY) was the recipient of a large decline in short interest during the month of September. As of September 15th, there was short interest totalling 227,800 shares, a decline of 21.7% from the August 31st total of 291,100 shares. Based on an average daily trading volume, of 40,700 shares, the short-interest ratio is currently 5.6 days.

Biotricity Stock Down 9.8 %

Biotricity stock traded down $0.03 during mid-day trading on Friday, hitting $0.25. 66,387 shares of the stock were exchanged, compared to its average volume of 75,328. The stock has a market capitalization of $5.41 million, a price-to-earnings ratio of -0.19 and a beta of 1.35. Biotricity has a 12 month low of $0.24 and a 12 month high of $2.22. The firm’s fifty day simple moving average is $0.46 and its two-hundred day simple moving average is $0.90.

Biotricity (OTCMKTS:BTCY) last announced its earnings results on Monday, August 19th. The company reported ($0.49) earnings per share for the quarter. The company had revenue of $3.20 million for the quarter. As a group, analysts forecast that Biotricity will post -1.43 earnings per share for the current fiscal year.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.